Bioengineered adipose-derived stem cells for targeted enzyme-prodrug therapy of ovarian cancer intraperitoneal metastasis
Author:
Funder
NIH/NCI
NIH/NCI Flow Cytometry
Biorepository and Histopathology
Shared Resources of the Rutgers-Cancer Institute of New Jersey
Publisher
Elsevier BV
Subject
Pharmaceutical Science
Reference51 articles.
1. Front-line therapy of advanced epithelial ovarian cancer: standard treatment;Marth;Ann. Oncol.,2017
2. Ovarian cancer stem cells: are they real and why are they important?;Shah;Gynecol. Oncol.,2014
3. Salvage chemotherapy for ovarian carcinoma recurring during or after consolidation chemotherapy with paclitaxel;Miyoshi;Anticancer Res.,2011
4. Veliparib and topotecan for patients with platinum-resistant or partially platinum-sensitive relapse of epithelial ovarian cancer with BRCA negative or unknown BRCA status;Hjortkjaer;Cancer. Treat. Res. Commun.,2018
5. Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial;Chekerov;Lancet Oncol.,2018
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adipose-derived stem cells promote glycolysis and peritoneal metastasis via TGF-β1/SMAD3/ANGPTL4 axis in colorectal cancer;Cellular and Molecular Life Sciences;2024-04-21
2. A quantitative MRI-based approach to estimate the permeation and retention of nanomedicines in tumors;Journal of Controlled Release;2024-04
3. Bispecific immune cell engager enhances the anticancer activity of CD16+ NK cells and macrophages in vitro, and eliminates cancer metastasis in NK humanized NOG mice;Journal for ImmunoTherapy of Cancer;2024-03
4. Human Pluripotent Stem Cell-Derived Mesenchymal Stem Cells for Oncotherapy;Advances in Pluripotent Stem Cells;2024-01-31
5. New insights in application of mesenchymal stem cells therapy in tumor microenvironment: pros and cons;Frontiers in Cell and Developmental Biology;2023-10-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3